Lenacapavir
id:
lenacapavir-189-6407146
title:
Lenacapavir
text:
Lenacapavir, sold under the brand name Sunlenca, is an antiretroviral medication used to treat HIV/AIDS. It is taken by mouth or by subcutaneous injection. The most common side effects include reactions at the injection site and nausea. Lenacapavir was approved for medical treatment in the European Union in August 2022, in Canada in November 2022, and in the United States in December 2022. It is the first of a class of drugs called capsid inhibitors to be approved by the US Food and Drug Adminis
brand slug:
wiki
category slug:
encyclopedia
description:
Antiretroviral medication
original url:
https://en.wikipedia.org/wiki/Lenacapavir
date created:
2021-03-15T22:56:50Z
date modified:
2024-09-09T06:51:38Z
main entity:
{"identifier":"Q105981469","url":"https://www.wikidata.org/entity/Q105981469"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/3/3d/Lenacapavir.svg","width":512,"height":377}
fields total:
13
integrity:
16